| Needs Assessment
Through needs assessment surveys, literature searches, advisory
board suggestions, and recent specialty publications, ImproMED
has identified that a need exists to educate ophthalmologists
on advances in glaucoma treatment. In recent years, published
results from several clinical trials have revealed data
that have led to the reconsideration of current glaucoma
treatment practices. Understanding these collective results
can help practicing ophthalmologists in making sound and
beneficial decisions with their patients for improved health
outcomes.
Target Audience
This activity is intended for general ophthalmologists and
those with a subspecialty in Glaucoma.
Overall Purpose
The purpose of this activity is to provide ophthalmologists
an understanding of how recently published results from
several clinical trials may affect their treatment strategies
for glaucoma patients.
Educational Objectives
Upon completion of this CME activity, participants should
have increased overall skills, knowledge, attitudes, and
performance, with a specific ability to:
Skill(s)
Identify recent significant clinical trials in glaucoma
Knowledge
Recognize the objectives, results, and clinical implications
of the various trials
Attitude(s)
Consider how the strengths and weaknesses inherent in
each of the trials affects the interpretation of results
Performance
Assess how the individual and collective results of the
trials impact clinical practice.
Designation of Credit Statement
ImproMED designates this educational activity for a maximum
of 1.0 category 1 credit toward the AMA Physician’s
Recognition Award. Each physician should claim only those
credits that he/she actually spent in the activity.
Disclosure Policy
It is the policy of ImproMED to ensure balance, independence,
objectivity, and scientific rigor in all its sponsored educational
activities. All faculty are expected to disclose to program
audiences any significant relationships related to the content
of their presentations.
Unapproved uses of drug regimens may be discussed.
 Activity
Review Committee
This activity was reviewed by Richard
K. Parrish II, MD, Activity Chair,
James Spindler,
MD, and Suzanne
Eggers.
Term of Approval: September 2003 through September
2004.
The certification periods for the following activities have expired, but the programs remain available for viewing. Please note that your participation in these activities is not eligible for AMA PRA category 1 credit, but may be eligible for AMA PRA category 2 credit. Please contact ImproMED with questions (seggers@impromed.org or 269.329.0651 x31) or view the AMA guidelines for PRA credit at http://www.ama-assn.org/ama/pub/category/2938.html.
|
